Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAPROPTERIN vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAPROPTERIN vs SAXAGLIPTIN: Safety Overview

Metric SAPROPTERIN SAXAGLIPTIN
Total FAERS Reports 5,539 2,468
Deaths Reported 60 263
Death Rate 1.1% 10.7%
Hospitalizations 339 838
Average Patient Age 23.3 yrs 65.5 yrs
% Female Patients 61.6% 47.8%
FDA Approval Date Apr 29, 2025 Jul 31, 2009
Manufacturer Dr. Reddys Laboratories Inc Glenmark Pharmaceuticals Inc., USA
Route ORAL ORAL
Marketing Status Prescription Discontinued